NCT01668511View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

ABT-981

Injection

BIOLOGICAL

Placebo

Placebo Injection

Trial Locations (1)

33136

Site Reference ID/Investigator# 78613, Miami

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01668511 - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter